Blockchain Registration Transaction Record

Mainz Biomed N.V. and Liquid Biosciences Partner to Fight Pancreatic Cancer

Mainz Biomed N.V. and Liquid Biosciences have teamed up to potentially add pancreatic cancer detection to the ColoAlert® screening test. This collaboration represents a significant step in the fight against pancreatic cancer, offering hope for earlier diagnosis and improved treatment outcomes.

This collaboration between Mainz Biomed and Liquid Biosciences is crucial in the battle against pancreatic cancer, one of the most lethal forms of the disease. The potential addition of pancreatic cancer detection to Mainz's screening test could lead to earlier diagnosis and better treatment outcomes for patients.